226 related articles for article (PubMed ID: 17357105)
1. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes.
Basler M; Groettrup M
Eur J Immunol; 2007 Apr; 37(4):896-904. PubMed ID: 17357105
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
[TBL] [Abstract][Full Text] [Related]
3. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.
Kawahara M; York IA; Hearn A; Farfan D; Rock KL
J Immunol; 2009 Nov; 183(10):6069-77. PubMed ID: 19841172
[TBL] [Abstract][Full Text] [Related]
5. Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement.
Diekmann J; Adamopoulou E; Beck O; Rauser G; Lurati S; Tenzer S; Einsele H; Rammensee HG; Schild H; Topp MS
J Immunol; 2009 Aug; 183(3):1587-97. PubMed ID: 19587004
[TBL] [Abstract][Full Text] [Related]
6. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.
York IA; Bhutani N; Zendzian S; Goldberg AL; Rock KL
J Immunol; 2006 Aug; 177(3):1434-43. PubMed ID: 16849449
[TBL] [Abstract][Full Text] [Related]
7. Role of tripeptidyl peptidase II in the processing of Listeria monocytogenes-derived MHC class I-presented antigenic peptides.
Grauling-Halama S; Bahr U; Schenk S; Geginat G
Microbes Infect; 2009; 11(8-9):795-802. PubMed ID: 19426827
[TBL] [Abstract][Full Text] [Related]
8. Analysis of direct and cross-presentation of antigens in TPPII knockout mice.
Firat E; Huai J; Saveanu L; Gaedicke S; Aichele P; Eichmann K; van Endert P; Niedermann G
J Immunol; 2007 Dec; 179(12):8137-45. PubMed ID: 18056356
[TBL] [Abstract][Full Text] [Related]
9. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope.
Seifert U; Marañón C; Shmueli A; Desoutter JF; Wesoloski L; Janek K; Henklein P; Diescher S; Andrieu M; de la Salle H; Weinschenk T; Schild H; Laderach D; Galy A; Haas G; Kloetzel PM; Reiss Y; Hosmalin A
Nat Immunol; 2003 Apr; 4(4):375-9. PubMed ID: 12598896
[TBL] [Abstract][Full Text] [Related]
10. Role of tripeptidyl peptidase II in MHC class I antigen presentation: Biological characteristics, cellular crosstalk and signaling.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Zang G; Tang Z
Biomed Pharmacother; 2016 Dec; 84():1954-1958. PubMed ID: 27829551
[TBL] [Abstract][Full Text] [Related]
11. Tripeptidyl peptidase II is dispensable for the generation of both proteasome-dependent and proteasome-independent ligands of HLA-B27 and other class I molecules.
Marcilla M; Villasevil EM; de Castro JA
Eur J Immunol; 2008 Mar; 38(3):631-9. PubMed ID: 18286573
[TBL] [Abstract][Full Text] [Related]
12. Role of tripeptidyl peptidase II in MHC class I antigen processing - the end of controversies?
Endert Pv
Eur J Immunol; 2008 Mar; 38(3):609-13. PubMed ID: 18286570
[TBL] [Abstract][Full Text] [Related]
13. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.
Reits E; Neijssen J; Herberts C; Benckhuijsen W; Janssen L; Drijfhout JW; Neefjes J
Immunity; 2004 Apr; 20(4):495-506. PubMed ID: 15084277
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
15. Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization.
Firat E; Tsurumi C; Gaedicke S; Huai J; Niedermann G
Cancer Res; 2009 Apr; 69(8):3325-31. PubMed ID: 19351849
[TBL] [Abstract][Full Text] [Related]
16. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection.
Basler M; Lauer C; Beck U; Groettrup M
J Immunol; 2009 Nov; 183(10):6145-50. PubMed ID: 19841190
[TBL] [Abstract][Full Text] [Related]
17. The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.
Urban S; Textoris-Taube K; Reimann B; Janek K; Dannenberg T; Ebstein F; Seifert C; Zhao F; Kessler JH; Halenius A; Henklein P; Paschke J; Cadel S; Bernhard H; Ossendorp F; Foulon T; Schadendorf D; Paschen A; Seifert U
J Immunol; 2012 Jul; 189(2):529-38. PubMed ID: 22706083
[TBL] [Abstract][Full Text] [Related]
18. A role for nuclear translocation of tripeptidyl-peptidase II in reactive oxygen species-dependent DNA damage responses.
Preta G; de Klark R; Glas R
Biochem Biophys Res Commun; 2009 Nov; 389(4):575-9. PubMed ID: 19747897
[TBL] [Abstract][Full Text] [Related]
19. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
20. Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins.
Basta S; Stoessel R; Basler M; van den Broek M; Groettrup M
J Immunol; 2005 Jul; 175(2):796-805. PubMed ID: 16002676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
